Global Retirement Partners’s Cymabay Therapeutics CBAY Stock Holding History

Global Retirement Partners’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,200	Closed	-$16.8K	–	3494
2023 Q3	$16.8K	Hold	1,200	–	–	﹤0.01%	1718
2023 Q2	$13.1K	Hold	1,200	–	–	﹤0.01%	1864
2023 Q1	$12.3K	Hold	1,200	–	–	﹤0.01%	1840
2022 Q4	$7.52K	Hold	1,200	–	–	﹤0.01%	1886
2022 Q3	$4K	Hold	1,200	–	–	﹤0.01%	2052
2022 Q2	$4K	Hold	1,200	–	–	﹤0.01%	2016
2022 Q1	$2K	Hold	1,200	–	–	﹤0.01%	2279
2021 Q4	$4K	Hold	1,200	–	–	﹤0.01%	202
2021 Q3	$4K	Hold	1,200	–	–	﹤0.01%	1724
2021 Q2	$5K	Hold	1,200	–	–	﹤0.01%	1602
2021 Q1	$5K	Hold	1,200	–	–	﹤0.01%	1497
2020 Q4	$7K	Hold	1,200	–	–	﹤0.01%	1377
2020 Q3	$9K	Hold	1,200	–	–	﹤0.01%	1189
2020 Q2	$4K	Buy	+1,200	New	+$3.46K	﹤0.01%	1358

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Global Retirement Partners's CBAY Position: Q4 2023 in Review

Global Retirement Partners sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 1,200 shares — an estimated $16.8K sold.

Global Retirement Partners first reported a position in CBAY in Q2 2020 and held it in 14 quarters. The position peaked at $16.8K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

Global Retirement Partners reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
Global Retirement Partners sold 1,200 Cymabay Therapeutics shares in Q4 2023, an estimated $16.8K.
Global Retirement Partners first reported a position in Cymabay Therapeutics in Q2 2020 and held it in 14 quarters.
Global Retirement Partners's Cymabay Therapeutics position peaked at $16.8K in Q3 2023.
200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Global Retirement Partners's 13F filing for Q4 2023, filed 18 Jan 2024.